Craig-Hallum upgraded Arhaus to Buy from Hold following the company's strong Q2 results, including record net revenue of approximately $385 million, a 7.4% increase year-over-year, and earnings per share of $0.28, which beat estimates by 75%. The company saw a 12.5% growth in comparable written sales and a 16.1% rise in gross margin to $172 million, partly boosted by a $23.8 million tariff refund. This strong performance highlights robust demand across Arhaus's product lines via e-commerce and showrooms, improving its financial outlook and investor confidence.
Flutter Entertainment's stock dropped 13% following a significant earnings miss and the announcement of CEO Peter Jackson's departure. The company reported Q2 earnings of $0.49 per share, well below the expected $0.60, and cut its full-year U.S. prof...
Attovia Therapeutics, a clinical-stage biopharmaceutical company, completed an upsized IPO by selling 19.55 million shares, including an underwriter option, raising approximately $332.40 million. The stock opened at $21.00 per share on Nasdaq and rea...
Aflac reported Q2 2026 earnings per share of $1.75, slightly below analyst estimates, while revenue of $4.12 billion narrowly exceeded projections. The company's improved profitability in Japan, highlighted by a better benefit-to-premium ratio of 61....
YXT.COM Group Holding Limited's stock plunged 66.07% following a registered direct offering that raised concerns about share dilution. The leveraged ETF Tradr 2X Long APP Daily ETF (APPX) fell 39.22%, highlighting the risks of leveraged products. Des...
Sanuwave Health reported Q2 2026 revenue of $9.7 million, down 3% from $10.1 million in Q2 2025, with a net loss of $0.7 million compared to net income last year. The company faced challenges from CMS reimbursement changes and a secondary market for ...
